イブニングセミナー1 EGFRエクソン20挿入変異陽性非小細胞肺癌の診療

[ES1-1] New clinical strategies for EGFR Ex20 ins mutated NSCLC

^○Nicolas Girard (Department of Medical Oncology, Institute Curie, Paris)